-
Pfizer’s Beqvez approved by FDA for haemophilia B treatment
Source: Pharmafile Published on 2024-04-29
-
J&J gains positive CHMP opinion for Rybrevant for treatment of lung cancer
Source: Pharmafile Published on 2024-04-29
-
Regeneron and Mammoth Biosciences announce CRISPR collaboration
Source: Pharmafile Published on 2024-04-26
-
ANGLE signs commercial agreement with AstraZeneca
Source: Pharmafile Published on 2024-04-26
-
Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement
Source: Pharmafile Published on 2024-04-25
-
Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment
Source: Pharmafile Published on 2024-04-25
-
Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals
Source: Pharmafile Published on 2024-04-24
-
GSK’s Jemperli accepted for FDA review for endometrial cancer treatment
Source: Pharmafile Published on 2024-04-24
-
Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia
Source: Pharmafile Published on 2024-04-23
-
FDA approves ImmunityBio’s Anktiva bladder cancer treatment
Source: Pharmafile Published on 2024-04-23
-
EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment
Source: Pharmafile Published on 2024-04-22
-
Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder
Source: Pharmafile Published on 2024-04-22
-
Ardena announces €20m expansion following first GMP approval
Source: Pharmafile Published on 2024-04-19
-
Roche’s Alecensa approved by FDA as lung cancer treatment
Source: Pharmafile Published on 2024-04-19
-
GSK shares results from phase 3 trial for gonorrhoea treatment
Source: Pharmafile Published on 2024-04-18